D. E. Raffik, “Novel Serum FABP4 and FABP4/ Adiponectin Ratio as Predictive Biomarkers of Metabolic Risk in Type 2 Diabetes”, CAJMNS, vol. 7, no. 1, pp. 49–59, Nov. 2025.